StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)

Close on Nov 18, 2026Market cap $46.20MP/E –Yield –

Mereo BioPharma total assets

Total assets on the balance sheet at the end of each period.

Mereo BioPharma's total assets was $29.58M at Sep 30, 2026. For fiscal 2025 it was $45.92M, down 39.9% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$45.92M-39.9%
FY2024Dec 31, 2024$76.39M+14.9%
FY2023Dec 31, 2023$66.50M-14.1%
FY2022Dec 31, 2022$77.41M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$29.58M-44.8%
Q2 FY2026Jun 30, 2026$34.71M-44.6%
Q1 FY2026Mar 31, 2026$40.61M-40.6%
Q4 FY2025Dec 31, 2025$45.92M-39.9%
Q3 FY2025Sep 30, 2025$53.60M-39.6%
Q2 FY2025Jun 30, 2025$62.63M-34.8%
Q1 FY2025Mar 31, 2025$68.32M+22.1%
Q4 FY2024Dec 31, 2024$76.39M+14.9%
Q3 FY2024Sep 30, 2024$88.75M+14.6%
Q2 FY2024Jun 30, 2024$96.13M–
Q1 FY2024Mar 31, 2024$55.94M–
Q4 FY2023Dec 31, 2023$66.50M–
Q4 FY2022Dec 31, 2022$77.41M–

More Mereo BioPharma figures

See a number that looks wrong?